Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NLRP3 inflammasome activation in alveolar epithelial cells promotes myofibroblast differentiation of lung-resident mesenchymal stem cells during pulmonary fibrogenesis
Jie Ji, Jiwei Hou, Yunhui Xia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2021) Vol. 1867, Iss. 5, pp. 166077-166077
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Benjamin J. Moss, Stefan W. Ryter, Iván O. Rosas
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 515-546
Closed Access | Times Cited: 419
Molecular Pathogenesis of Pulmonary Fibrosis, with Focus on Pathways Related to TGF-β and the Ubiquitin-Proteasome Pathway
Naoki Inui, Satoshi Sakai, Masatoshi Kitagawa
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6107-6107
Open Access | Times Cited: 97
Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance
Ya Liu, Haibo Lei, Wenyou Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 31
Suppressing NLRP3 activation and PI3K/AKT/mTOR signaling ameliorates amiodarone-induced pulmonary fibrosis in rats: a possible protective role of nobiletin
Manar Mohammed El Tabaa, Maram Mohammed El Tabaa, Rehab M. Elgharabawy, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1373-1386
Closed Access | Times Cited: 20
Pediatric obesity and severe asthma: Targeting pathways driving inflammation
Maria Di Cicco, Michele Ghezzi, Ahmad Kantar, et al.
Pharmacological Research (2023) Vol. 188, pp. 106658-106658
Open Access | Times Cited: 19
The role of the NLRP3 inflammasome in chronic inflammation in asthma and chronic obstructive pulmonary disease
Yaxin Wu, Xin Di, Min Zhao, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 12
Open Access | Times Cited: 23
Cuproptosis-related gene CDKN2A as a molecular target for IPF diagnosis and therapeutics
Baowen Xu, Kaiyong Yang, Xin Han, et al.
Inflammation Research (2023) Vol. 72, Iss. 6, pp. 1147-1160
Closed Access | Times Cited: 11
Current state of signaling pathways associated with the pathogenesis of idiopathic pulmonary fibrosis
Yang Zhou, Tingting Ling, Weihong Shi
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Mechanisms of Bleomycin-induced Lung Fibrosis: A Review of Therapeutic Targets and Approaches
Shaimaa M. Mohammed, Haider Falih Shamikh Al-Saedi, Amjed Qasim Mohammed, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1845-1870
Closed Access | Times Cited: 4
Predictive and personalized approaches for idiopathic pulmonary fibrosis: a Wnt-related gene set scoring framework integrating single-cell sequencing, spatial transcriptomics, and machine learning for diagnosis and prognosis
Qijian Ji, Lei Jiang, Fei Gao, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Exploring the mitigating potential of anthocyanin Malvidin in a mouse model of bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and oxidative stress
Dingzi Zhou, Lin Cai, Jie Yu, et al.
Journal of Inflammation (2025) Vol. 22, Iss. 1
Open Access
T-2 Toxin Induces Kidney Fibrosis via the mtROS-NLRP3-Wnt/β-Catenin Axis
Xuliang Zhang, Bo Li, Siming Huo, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 42, pp. 13765-13777
Closed Access | Times Cited: 17
Simvastatin Inhibits NLRP3 Inflammasome Activation and Ameliorates Lung Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia via the KLF2-Mediated Mechanism
Xinye Wang, Ran Huo, Zhongjie Liang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 16
Perspectives of PDE inhibitor on treating idiopathic pulmonary fibrosis
Xudan Yang, Zhihao Xu, Songhua Hu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
The role of immunosuppressive myofibroblasts in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2023) Vol. 101, Iss. 10, pp. 1169-1189
Open Access | Times Cited: 10
Mitochondrial Dysfunction in Lung Resident Mesenchymal Stem Cells from Idiopathic Pulmonary Fibrosis Patients
Josep Mercader, Aina Martín-Medina, Joan Truyols-Vives, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2084-2084
Open Access | Times Cited: 9
Role of Pyroptosis in Respiratory Diseases and its Therapeutic Potential
Jingjing Liu, Guoqing Fan, Ningning Tao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 2033-2050
Open Access | Times Cited: 14
A systematic review of the research progress of traditional Chinese medicine against pulmonary fibrosis: from a pharmacological perspective
Shanbo Qin, Peng Tan, Junjie Xie, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 8
New Potentiality of Bioactive Substances: Regulating the NLRP3 Inflammasome in Autoimmune Diseases
B Chen, Yuhua Wang, Guangjie Chen
Nutrients (2023) Vol. 15, Iss. 21, pp. 4584-4584
Open Access | Times Cited: 8
NR1D1 deficiency in the tumor microenvironment promotes lung tumor development by activating the NLRP3 inflammasome
Sun Mi Kim, Yoon Jeon, Ji Yun Jang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 7
AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration
Antero Salminen
Biogerontology (2023) Vol. 25, Iss. 1, pp. 83-106
Open Access | Times Cited: 7
Linking NLRP3 inflammasome and pulmonary fibrosis: mechanistic insights and promising therapeutic avenues
Shobhit Gairola, Antarip Sinha, Ravinder K. Kaundal
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 287-305
Closed Access | Times Cited: 7
In Vivo and In Vitro Pro-Fibrotic Response of Lung-Resident Mesenchymal Stem Cells from Patients with Idiopathic Pulmonary Fibrosis
Gabriel Escarrer-Garau, Aina Martín-Medina, Joan Truyols-Vives, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 160-160
Open Access | Times Cited: 2
Ginsenoside Rb1 Alleviates Bleomycin-Induced Pulmonary Inflammation and Fibrosis by Suppressing Central Nucleotide-Binding Oligomerization-, Leucine-Rich Repeat-, and Pyrin Domains-Containing Protein Three Inflammasome Activation and the NF-κB Pathway
Jingjing Liu, Guoqing Fan, Ningning Tao, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1793-1809
Open Access | Times Cited: 11
Notch signaling regulates pulmonary fibrosis
Xinyue Zhang, Zhihao Xu, Qi Chen, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top